MARIO GONZALEZ: Open Payments
NPI 1396377925 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,503 in 25 payments from 15 companies in 2025. Trend: 2023 $1,327 · 2024 $579 · 2025 $1,503
Food & beverage: $1,503
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $396 |
| Ascendis Pharma Endocrinology Inc | 2 | $143 |
| Becton, Dickinson and Company | 1 | $132 |
| JAZZ PHARMACEUTICALS INC. | 1 | $122 |
| AKEBIA THERAPEUTICS INC | 1 | $122 |
| SCPHARMACEUTICALS INC. | 2 | $120 |
| Novo Nordisk Inc | 1 | $109 |
| Globus Medical, Inc. | 2 | $86 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $77 |
| Ardelyx, Inc. | 2 | $56 |
Products named: TAVNEOS, Yorvipath, HemoSphere, ZEPZELCA, Vafseo, FUROSCIX, KRYSTEXXA, Ozempic.
Industry payments across TX — which companies pay providers there.
